These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30342717)

  • 1. Metformin Associated With Improved Outcomes in Diabetic Patients With Laryngeal and Oropharyngeal Carcinoma.
    Ogunsakin A; Infield J; Zuber J; Solomon SS
    Am J Med Sci; 2018 Dec; 356(6):574-575. PubMed ID: 30342717
    [No Abstract]   [Full Text] [Related]  

  • 2. Cetuximab is effective, but more toxic than reported in the Bonner trial.
    Lord HK; Junor E; Ironside J
    Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):96. PubMed ID: 17928207
    [No Abstract]   [Full Text] [Related]  

  • 3. The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study.
    Spratt DE; Beadle BM; Zumsteg ZS; Rivera A; Skinner HD; Osborne JR; Garden AS; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):523-531. PubMed ID: 26867881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma.
    Sandulache VC; Hamblin JS; Skinner HD; Kubik MW; Myers JN; Zevallos JP
    Head Neck; 2014 Jul; 36(7):1039-43. PubMed ID: 23784886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-oncogenic effect of metformin].
    Noto H
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():693-6. PubMed ID: 27266176
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vincristine-bleomycin-methotrexate in the treatment of recurrence of ORL carcinoma].
    Airoldi M; Pedani F; Gabriell P; Giordano C; Pia F
    Acta Otorhinolaryngol Ital; 1988; 8(2):125-31. PubMed ID: 2461045
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction chemotherapy for organ preservation in advanced squamous cell carcinoma of the oral cavity and oropharynx.
    Wolf GT; Urba S; Hazuka M
    Recent Results Cancer Res; 1994; 134():133-43. PubMed ID: 8153429
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality of life outcomes in laryngeal and oropharyngeal cancer patients after chemoradiation.
    Mowry SE; LoTempio MM; Sadeghi A; Wang KH; Wang MB
    Otolaryngol Head Neck Surg; 2006 Oct; 135(4):565-70. PubMed ID: 17011418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and pancreatic cancer: a clue requiring investigation.
    Pollak M
    Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cracking open window of opportunity trials.
    Kalinsky K; Hershman DL
    J Clin Oncol; 2012 Jul; 30(21):2573-5. PubMed ID: 22565006
    [No Abstract]   [Full Text] [Related]  

  • 11. Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?
    Martin M; Marais R
    J Clin Oncol; 2012 Jul; 30(21):2698-700. PubMed ID: 22565000
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major.
    Dhouib N; Turki Z; Mellouli F; Ouederni M; Yahiaoui S; Nagi S; Ben Slama C; Bejaoui M
    Tunis Med; 2010 Feb; 88(2):136. PubMed ID: 20415181
    [No Abstract]   [Full Text] [Related]  

  • 13. Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.
    Pusceddu S; Buzzoni R; Vernieri C; Concas L; Marceglia S; Giacomelli L; Milione M; Leuzzi L; Femia D; Formisano B; Mazzaferro V; de Braud F
    Future Oncol; 2016 May; 12(10):1251-60. PubMed ID: 26890290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing to fight cancer: the metformin-prostate cancer connection.
    Azvolinsky A
    J Natl Cancer Inst; 2014 Feb; 106(2):dju030. PubMed ID: 24511112
    [No Abstract]   [Full Text] [Related]  

  • 15. Glutathione peroxidases in human head and neck cancer.
    Mulder TP; Manni JJ; Roelofs HM; Peters WH; Wiersma A
    Acta Otolaryngol; 1995 Mar; 115(2):331-3. PubMed ID: 7610835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
    Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
    Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of life after simultaneous radiochemotherapy in squamous cell carcinoma of the head and neck].
    Wendt TG
    Strahlenther Onkol; 2000 Apr; 176(4):198-200. PubMed ID: 10812396
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy alone for laryngeal preservation--is it possible?
    Forastiere AA; Shaha AR
    J Clin Oncol; 2009 Apr; 27(12):1933-4. PubMed ID: 19289612
    [No Abstract]   [Full Text] [Related]  

  • 19. Bcl-2 as a target in laryngeal squamous cell carcinoma.
    S Mastronikolis N; Tsiambas E; Fotiades PP; Ragos V
    J BUON; 2019; 24(2):865. PubMed ID: 31128052
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes mellitus, metformin and head and neck cancer.
    Figueiredo RA; Weiderpass E; Tajara EH; Ström P; Carvalho AL; de Carvalho MB; Kanda JL; Moyses RA; Wünsch-Filho V
    Oral Oncol; 2016 Oct; 61():47-54. PubMed ID: 27688104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.